Stocktoria
Guardant Health, Inc. GH
Nasdaq · XNAS · stock · Services-Medical Laboratories · website · IPO 2018-10-04
Guardant Health, Inc. financials (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $982.0M | $739.0M | $563.9M | $449.5M | $373.7M |
| R&D expense | $364.2M | $347.8M | $367.2M | $373.8M | $263.2M |
| Operating income | -$437.2M | -$443.6M | -$564.7M | -$544.4M | -$411.0M |
| Interest expense | — | — | $2.6M | $2.6M | $2.6M |
| Income tax | -$1.3M | $1.3M | $685,000 | $1.1M | $300,000 |
| Net income | -$416.3M | -$436.4M | -$479.4M | -$654.6M | -$384.8M |
| EPS (diluted) | $-3.32 | $-3.56 | $-4.28 | $-6.41 | $-4.00 |
| Operating cash flow | -$184.8M | -$239.9M | -$325.0M | -$309.5M | -$209.0M |
| Free cash flow | -$233.1M | -$274.9M | -$345.5M | -$386.9M | -$284.1M |
| Cash & equivalents | $378.2M | $525.5M | $1.1B | $141.6M | $492.2M |
| Inventory | $85.9M | $71.1M | $61.9M | $51.6M | $30.7M |
| Total assets | $2.0B | $1.5B | $1.8B | $1.6B | $2.2B |
| Total liabilities | $2.1B | $1.6B | $1.6B | $1.5B | $1.6B |
| Shareholders' equity | -$99.3M | -$139.6M | $158.7M | $60.2M | $645.0M |
Source: SEC EDGAR filings · CIK 0001576280 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.